Frontlight ResearchEarly access
Trial site
Instituto Jalisciense de Investigacion en Diabetes y Obesidad
- 5running trials
- 6closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Type 2 diabetes9 trials
- Obesity3 trials
- Chronic kidney disease2 trials
- Stroke2 trials
- Type 1 diabetes2 trials
- Coronary artery disease1 trial
- Heart failure1 trial
- Peripheral artery disease1 trial
- Phase
- Phase 311 trials
- Status
- Completed6 trials
- Not yet recruiting3 trials
- Active, not recruiting2 trials
- Lead sponsor
- Eli Lilly and Company9 trials
- Novo Nordisk A/S2 trials
Running trials
Recruiting
Recruiting
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Type 2 diabetes2 recruiting
- Chronic kidney disease1 recruiting
- Obesity1 recruiting
- Stroke1 recruiting
- Type 1 diabetes1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 14 Nov 2026